cycloheximide has been researched along with homoharringtonine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL | 1 |
| Lin, MF; Mai, WY | 1 |
| Carrier, M; Chen, S; Lowe, S; Pelletier, J; Rawe, S; Robert, F | 1 |
| Adam, D; Kalthoff, H; Philipp, S; Plenge, J; Sosna, J | 1 |
1 review(s) available for cycloheximide and homoharringtonine
| Article | Year |
|---|---|
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization | 2021 |
3 other study(ies) available for cycloheximide and homoharringtonine
| Article | Year |
|---|---|
Induction of apoptosis by homoharringtonine in G1 phase human chronic myeloid leukemic cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cycloheximide; Dactinomycin; G1 Phase; Harringtonines; Homoharringtonine; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2005 |
Altering chemosensitivity by modulating translation elongation.
Topics: Animals; Base Sequence; Cell Line, Tumor; Cyclin D1; Cycloheximide; Depsipeptides; DNA Primers; Drug Resistance, Neoplasm; Eukaryotic Initiation Factor-4E; Female; Genes, bcl-2; Genes, myc; Harringtonines; Homoharringtonine; Lymphoma; Mice; Mice, Inbred C57BL; Mutation; Myeloid Cell Leukemia Sequence 1 Protein; Peptide Chain Elongation, Translational; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; PTEN Phosphohydrolase; Quassins; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2009 |
Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cycloheximide; Harringtonines; Homoharringtonine; Humans; Necrosis; Neoplasms; Protein Synthesis Inhibitors; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand | 2015 |